Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.

As part of its ongoing RAK Diabetes Challenge community initiative, RAK Hospital held an insightful Diabeat Webinar on the ...

People with diabetes face a number of health challenges related to their chronic condition, and loss of vision due to retinal ...

India contributes nearly one-sixth to the global disease burden of 422 million. Though diabetes is caused by a complex ...

People with diabetes face a number of health challenges related to their chronic condition, and loss of vision due to retinal ...

Gestational diabetes mellitus (GDM) is a pervasive metabolic disorder associated with a spectrum of long-term adverse ...

A recent case report highlights the importance of understanding the possibility of the development of Euglycemic diabetic ...

Sodium glucose cotransporter 2 inhibitors used to treat diabetes may also reduce the risk of recurrent kidney stones and gout ...

Sernova’s technology helped type 1 diabetes patients achieve insulin independence in early- and mid-stage trials.

The FDA rejected sotagliflozin 5 years ago for the same indication but for the broader population of adults with T1D, due to ...